Author:
Phyu Su M.,Tseng Chih-Chung,Fleming Ian N.,Smith Tim A. D.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Zheng, Z. et al. Targeting cytosolic phospholipase A(2)alpha in colorectal cancer cells inhibits constitutively activated Protein Kinase B (AKT) and cell proliferation. Oncogene 5, 12304–12316 (2014).
2. Bhaskar, P. T. & Hay, N. The two TORCs and Akt. Dev.Cell 12, 487–502 (2007).
3. Carnero, A., Blanco-Aparicio, C., Renner, O., Link, W. & Leal, J. F. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8, 187–198 (2008).
4. Yap, T. A., Bjerke, L., Clarke, P. A. & Workman, P. Drugging PI3K in cancer: refining targets and therapeutic strategies. Curr. Opin. Pharmacol. 23, 98–107 (2015).
5. Polivka Jr, J. & Jankuc, F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol. Therapeut . 142, 164–175 (2014).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献